Sign in
4

Changes in Ownership

Kalaris Therapeutics, Inc. Filed Acc 0000950170-25-041475

Options or other derivatives

  • Director acquired 32,473 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

ADAMIS ANTHONY P · Director

Table II: Derivative

2 lines
Date Transaction Shares Owned after D/I
2025-03-18 Grant or award : show line 1 in the form Stock Option (right to buy) +19,484 19,484 D
2025-03-18 Grant or award : show line 2 in the form Stock Option (right to buy) +12,989 12,989 D
Loading xslF345X05/ownership.xml…